Home › Markets › Health Care › MBIO

Mustang Bio Inc. (MBIO)

MBIO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.3768
-8.63% on the day
Market cap
$2.9M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerMBIO on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001680048
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-09-05
Latest annual report10-K2026-03-19
Latest quarterly / interim10-Q2026-08-05
Latest current report
FORM 8-K
8-K2026-04-17
Latest proxyDEF 14A2025-12-03

Source: SEC EDGAR submissions feed, 402 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
PRFXPRF Technologies Ltd.$0.8180-4.88%$2.9M
HCWBHCW Biologics Inc.$1.26-14.87%$2.8M
KAPAKairos Pharma Ltd.$0.8287-0.40%$2.8M
ONCOOnconetix Inc.$0.5550-6.00%$2.9M
DCOYDecoy Therapeutics Inc.$1.24-13.29%$3.0M
GOVXGeoVax Labs Inc.$0.2656-5.92%$2.7M
XRTXXORTX Therapeutics Inc. Common Shares$1.68-2.33%$3.1M
APVOAptevo Therapeutics Inc.$1.73-5.79%$3.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier